Reuters logo
BRIEF-Portola Pharmaceuticals says U.S. FDA approves blood-thinner Bevyxxa to prevent clots
June 23, 2017 / 6:55 PM / 3 months ago

BRIEF-Portola Pharmaceuticals says U.S. FDA approves blood-thinner Bevyxxa to prevent clots

June 23 (Reuters) - Portola Pharmaceuticals Inc :

* U.S. FDA approves Bevyxxa® (Betrixaban) first and only anticoagulant for hospital and extended duration prevention of Venous Thromboembolism (VTE) in acutely ill medical patients

* Portola Pharmaceuticals Inc- Timeline on which portola expects to launch Bevyxxa is between August and November 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below